Chemfab Alkalis Reports Strong Q1 FY26 Financial Results; Board Approves, Director Resigns
The announcement includes the company's unaudited financial results for Q1 FY26, which show strong growth in revenue and profit, indicating positive operational performance. This information is crucial for investors' valuation and future outlook. Additionally, the resignation of a director and the subsequent reconstitution of key committees represent important corporate governance updates.
The company reported a substantial increase in net profit after tax for Q1 FY26, both on a standalone (₹539.40 lakh vs ₹332.89 lakh YoY) and consolidated basis (₹254.76 lakh vs ₹89.57 lakh YoY). Revenue from operations also saw good growth. The reassessment of depreciation for the PVC-O Division further contributed positively to profits.
Chemfab Alkalis Limited announced its unaudited standalone and consolidated financial results for the quarter ended 30 June 2025. * Standalone Performance: * Revenue from Operations increased to ₹875.81 lakh from ₹760.40 lakh in the corresponding quarter of the previous year (Q1 FY25). * Net Profit after Tax rose significantly to ₹539.40 lakh, compared to ₹332.89 lakh in Q1 FY25. * Basic Earnings Per Share (EPS) stood at ₹3.76, up from ₹3.04 in Q1 FY25. * Consolidated Performance: * Revenue from Operations grew to ₹915.40 lakh from ₹765.31 lakh in Q1 FY25. * Net Profit after Tax increased to ₹254.76 lakh, against ₹89.57 lakh in Q1 FY25. * Basic Earnings Per Share (EPS) was ₹1.77, compared to ₹0.63 in Q1 FY25. * The company noted that during the quarter, reassessment of the estimated useful life of certain plant and machinery in the PVC-O Division led to a lower depreciation of ₹259.00 lakh per quarter, applied prospectively. * The Board also approved the allotment of 4,000 equity shares of ₹10 each under the Chemfab Alkalis Employees Stock Options Scheme (CAESOS 2020). * Mr. C. S. Ramesh resigned as a Non-Executive and Non-Independent Director, effective from the close of business hours on 31 July 2025. * Following the resignation, the Board approved the reconstitution of various committees, including the Audit Committee, Nomination and Remuneration Committee, CSR Committee, and Stakeholders Relationship Committee.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.